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During the human B cell (Bc) recall response, rapid cell division results in multiple Bc subpopulations. The
TLR-9 agonist CpG oligodeoxynucleotide, combined with cytokines, causes Bc activation and division in
vitro and increased CD27 surface expression in a sub-population of Bc. We hypothesized that the
proliferating CD27
lo subpopulation, which has a lower frequency of antibody-secreting cells (ASC) than
CD27
hi plasmablasts, provides alternative functions such as cytokine secretion, costimulation, or antigen
presentation. We performed genome-wide transcriptional analysis of CpG activated Bc sorted into
undivided, proliferating CD27
lo and proliferating CD27
hi subpopulations. Our data supported an
alternative hypothesis, that CD27
lo cells are a transient pre-plasmablast population, expressing genes
associated with Bc receptor editing. Undivided cells had an active transcriptional program of non-ASC B
cell functions, including cytokine secretion and costimulation, suggesting a link between innate and
adaptive Bc responses. Transcriptome analysis suggested a gene regulatory network for CD27
lo and
CD27
hi Bc differentiation.
Introduction
Several groups have suggested a ‘‘division of labor’’ between populations of re-activated memory B cell (mBc).
Some of the proposed binary classifications include: antibody versus cytokine producing Bc
1,2, effector versus
regulatory Bc (Reviewed in
3), plasma cells versus resting mBc
4, and central versus effector mBc
1. Such classifica-
tion schemata generally focus on the terminal functions of activated naı ¨ve Bc
5,6, rather than the early differenti-
ation of re-activated mBc. However, it is not clear that activated and dividing mBc can be partitioned into only 2
categories: antibody secretion and another function, or how adjuvants like oligodeoxynucleotides (CpG), may
alter such a balance.
Among the biological activities of activated IgG class-switched, mBc are division, antibody secretion, cytokine
secretion, and antigen presentation (reviewed in
7). In several in vitro Bc activation systems, 30–50% of activated
Bc become antibody secreting cells (ASC) by the third cell division
8,9. In vivo, such activation takes place at the T
cell zone-lymphoid follicle border, where Bc undergo co-stimulation with T follicular helper cells (TFh).
Activated mBc present antigen and provide reciprocal cytokine stimulation to T cells
10,11.
BcactivationandproliferationcanalsobeinducedbyCpGactingthroughToll-likereceptor9(TLR-9).TLR-9
agonists improve production of antibody by Bc responding to vaccine
12, and are in clinical trials as vaccine
adjuvants
13. We have previously shown that a combination of CpG2008 ODN and cytokines (IL-2, IL-10, IL-15,
and BAFF) can induce in vitro mBc differentiation into CD138
1plasma cells
9. Previously, a division of labor was
postulated between CpG-activated Bc, including a partition into antibody and cytokine-secreting cells
14.
However, these studies have not examined the potential signaling networks and transcriptome patterns in the
subsets of CpG-activated mBc. Such an analysis is important in understanding the differences between TFh and
TLR-9 activated mBc and the antibody response generated by these two pathways, especially with respect to Bc
responses to TLR-9 adjuvanated vaccines
15,16.
Here we have used transcriptome analysis to characterize differences between CpG ODN activated, class
switched, human mBc in three phenotypic categories: non-dividing, activated dividing, and activated-
dividing-antibody secreting Bc. Our group and others have previously described increased surface expression
of CD27 as correlating with division-dependent antibody secretion in CpG stimulated CD27
1 class switched
mBc
9,17. CD27
hi cells have a higher frequency of antibody-secreting cells than CD27
lo cells
18. For this reason, we
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lo cells provide other germinal center Bc
functions such as cytokine production, antigen presentation or co-
stimulation for T cells. Vaccine adjuvants such as CpG may alter the
balance between these states.
To this end, we describe significant differences between gene
expression patterns of CpG-activated CD27
hi IgG secreting versus
CD27
lo non-secreting mBc. These transcription patterns suggest
two gene expression pathways in proliferating CpG activated mBc,
with upregulation of antibody production pathways in the CD27
hi
subset, and upregulation of NF-kB activation pathways in the
CD27
lo subset preceding differentiation into a plasmablast pheno-
type. Gene expression patterns in undivided cells showed surpris-
inglyactivetranscriptionofantigenpresentation,cytokinesecretion,
and co-stimulation genes.
Results
CpG-stimulated human memory B cells are CD27 heterogeneous.
To investigate a potential division of labor between the CD27
hi and
CD27
lo cellsubsets, we tested thehypothesisthat CD27
lo cells function
in antigen presentation, co-stimulation or cytokine production. CpG
activated human mBc exhibit considerable heterogeneity as they
divide and differentiate, especially with respect to IgG secretion and
secretion rates. In vitro CpG ODN stimulation of IgG class-switched,
CD27
1 human peripheral blood mBc leads to development of a
CD27
hi pre-plasmablast subset containing a higher frequency of
ASC than the corresponding CD27
lo subset, although IgG secretion
rates among ASC in either group are identical
18.
At 96 hours of stimulation with CpG plus a combination of cyto-
kines (IL-2, IL-10, IL-15; CpG 1 CK), IgG class switched human
mBc show increased intracellular IgG after two cell divisions
(Fig. 1a), and heterogeneous expression of CD27 (Fig. 1b). The frac-
tion of CD27
hi cells increased in each generation up to division 4
(Fig. 1c). Quantitative ELISPOT (qELISPOT) assays (Fig.1d) show a
typical bimodal distribution of single-cell IgG secretion rates, and an
IgG secreting cell frequency of only 27%. To examine the functional
activities of CpG-activated and dividing CD27
lo cells, we sorted
CD19
1Bcat96 hoursintoCD27
hi,CD27
lo,andundividedcellpopu-
lations (sort gates shown in Supplementary Fig. S1 online), and
performed genome-wide transcriptome analysis. While CD19 levels
decreased modestly on proliferating cells, .95% of cells were within
the CD191 sort gate. Relative CD27 gene levels were as expected for
the sorted subsets (see Supplementary Fig. S2 online). Control ana-
lysisofCD3,CD4,CD8AandCD8BmRNAexpressionbygenearray
and analysis of CD3 by qRT-PCR showed no evidence of contam-
ination by T cells (see Supplementary Fig. S2 online).
We first analyzed gene array results for significant differences
between the CD27
hi, CD27
lo, and undivided cell populations from
the same subject by using a paired SAM analysis. 6,954 probe sets
were found to be significantly differentially expressed between
CD27
lo and undivided at false discovery rate (FDR) level 0.01. We
selected 4,615 differentially expressed genes based on the following
criterion: a gene is declared differentially expressed if at least
one associated probe set was significantly differentially expressed.
When a more stringent significance level was used (FDR50.008),
3,093 probe sets (2,238 genes) were found significant (Table 1). This
Figure 1 | Human Memory B Cell CD27 Expression is Heterogeneous at 96 hr CpG1CK Stimulation. Normal human peripheral blood Bc were
depletedofIgM1cells,stainedwithcarboxyfluorosceinsuccinimidylester(CFSE),whichdecreasesinconcentrationwitheachcelldivision,andplacedin
culturewithCpGODN1IL2,IL10,IL15,andBAFF.(a)At96 hrsofstimulation,flowcytometricanalysisshowedintracellularIgGcontent increasedin
divisions 2–5 and (b) only a subset of cells in divisions 2–5 have increased in CD27 expression as compared with undivided cells. (c) The percentage of
CD27
hi cells per generation increases in divisions 2 through 4, with an apparent decrease in division 51 that may be due to the spread of the data.
Representative data from 1 subject, n510 subjects in 5 separate experiments. (d) Histogram of semi-quantitative ELISPOT data at this timepoint shows
biphasicIgGsecretionrateoftheearlyrecallresponse,butonly27%ofcellssecretingIgG.CellswereFACSsortedintoCD27
lo,CD27
hi,andundividedcells
subsets as in (b) for gene array analysis. Representative data from 1 subject, n510 subjects in 5 separate experiments.
Table 1 | Statistical Analysis of Microarray (SAM). SAM analysis was performed on matched B cell subpopulations isolated from 6 human
subjects. Genes appearing in these sets with are noted in the following heatmaps by the symbols indicating their corresponding FDR
Comparison FDR Number of Differentially Expressed Probes Number Differentially Expressed Genes Symbol
Undivided: CD27
Hi 0.008 8,316 5,299
Undivided: CD27
Hi 0.01 11,174 6,607
Undivided: CD27
Lo 0.008 3,093 2,238 (**)
Undivided: CD27
Lo 0.01 7,500 4,434 (*)
CD27Lo: CD27
Hi 0.008 4 4
CD27Lo: CD27
Hi 0.01 7 5
CD27Lo: CD27
Hi 0.03 2,746 1,815 (
{)
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 345 | DOI: 10.1038/srep00345 2represents a large difference between these two cell populations.
When comparing CD27
hi to CD27
lo cells at FDR50.01 level, only 7
probe sets were found to be significantly different. The lack of stat-
istical power is due to two reasons: a) some overlap of the cell popu-
lations as sorted b) the sample size of this study (six individuals) is
relatively small and we are using a very rigorous significant level
for testing gene differentiation. When FDR50.03 was used for this
comparison, we were able to find 2,771 significant probe sets (2,033
genes). Expression levels of several biologically relevant genes were
confirmed by subsequent quantitative RT-PCR experiments (p-
values in Supplementary Table S2). Row-normalized heatmaps
(Fig. 2, Fig. 3, Fig. 4 and Fig. 5) show genes with at least one probe
set that was significantly different between CD27
lo and CD27
hi ({),
genesinthecomparisonofCD27
lotoundividedcellsthathadatleast
Figure 2 | CD27
lo cells do not predominantly express antigen presentation/co-stimulation molecules or cytokines. (a) Row-normalized heatmaps of
genome-wide transcriptional analysis using Affymetrix U133 2.0 Plus gene arrays (n56 subjects). All probes are shown for each gene plotted. With the
exception of CD80, most genes for antigen presentation/co-stimulation were expressed at higher levels in undivided cells. A dagger ({) indicates genes
with at least one probe that was found by SAM analysis to be significantly different between CD27
lo and CD27
hi at FDR50.03 (n52746 probes). An
asterisk is (*) indicates genes in the comparison of undivided to CD27
lo cells that had at least one probe significantly different at FDR50.01 (n57500
probes) and two asterisks (**) are next to genes that were still significant (CD27
lo/undivided comparison) at FDR50.008 (n53093 probes). (b)
Quantitative RT-PCR confirmed relative RNA levels of CD40, CD74, CD80, and CD83 (n510 subjects, including the same 6 subjects analyzed by
genearray) (pairedT-testpvaluesinSupplementaryTable2).Thepointineachviolinplot isthemedian valueandthe bracketsindicatethe interquartile
range with the addition of the probability density of the data at different values. (c) Flow cytometric analyses of normal human Bc stimulated for 96 hr
withCpG1CKconfirmedrelativeproteinlevelspergenerationconsistentwithRNAlevelsforCD80andCD83andahigherpercentageofCD27
locellsin
divisions1and2(n53subjects).Theundividedsubpopulationexpresseshigherlevelsofthesegenes.(d)GenearrayanalysisshowsmessagesforIL-6,IL-
7, IL-24, TNFSF12 (April), Lymphotoxin A (LTA), produced in larger amounts by undivided cells than the other cell subsets. While TNF and IL1A were
significantly different between groups at an FDR50.03, they were not significant at lower FDRs (n56 subjects). (e) Relative IL-6 RNA levels were
confirmed by qRT-PCR. (n510, paired T-test p values in Supplementary Table 2). The point in each violinplot is the median value and the brackets
indicatetheinterquartilerangewithadditionoftheprobabilitydensityofthedataatdifferentvalues.ExceptforIL-15,theundividedcellsproducehigher
amounts of these cytokine messages. IL-15 message was significantly higher in CD27
hi cells than in CD27
lo.
www.nature.com/scientificreports
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FDR50.01 level (*) or FDR50.008 (**).
Do CpG induced CD27
lo Bc function as antigen presenting,
co-stimulating or cytokine secreting cells? As co-stimulation
molecules have been shown to be expressed in mBc culture systems
19,20
we hypothesized that CpG-stimulated CD27
lo Bc would have
transcriptome patterns rich in antigen presentation and co-stimulation
molecules. We therefore examined the relative gene expression levels of:
CD22, CD24, CD40, CD69, CD74, CD80, CD81, CD83, CD84, CD86,
CD96, Class II Transcriptional Activator (CIITA), and HLA antigens.
Figure 2a shows expression levels for selected genes in each subset
(CD27
hi, CD27
lo and undivided). Undivided Bc had higher express-
ion of transcripts for proteins involved in T cell-B cell adhesion,
co-stimulation and antigen presentation, including: CD40, CD83,
CD74, CD96, and CIITA. RNA levels for HLA antigens including,
HLA-DP HLA-DQ, and HLA-DR were at higher levels in undivided
cells. Consistent with increased antigen presenting activity, tran-
scripts for proteins involved in MHC class II assembly, HLA-DO
andHLA-DMwerealsomorehighlyexpressedintheundividedcells
than the CD27
lo and the CD27
hi cells. In contrast, the co-stimulatory
proteinCD80hadhigherexpressionlevelsinCD27
locellsthaninthe
other cell subsets. CD86 transcript levels were slightly higher in
CD27
lo cells, however were not significantly different from CD27
hi
and Undivided cells. We confirmed the gene array results for CD40,
CD74, CD80 and CD83 with quantitative RT-PCR (Fig. 2b).
Supplementary Table 2 contains p-values from unadjusted paired
t-test for comparisons of qRT-PCR data from all 3 cell subsets.
Figure 3 | CD27
lo cells produce activation-induced cytidine deaminase (AICDA, AID). AICDA and EXO1, which have been implicated in somatic
hypermutation and class-switch recombination, have more abundant mRNA levels inCD27
lo cells. This suggests that the cells may be undergoing receptor
editing. IL2RA was also expressed at higher levels by CD27
lo cells. CCL22, CD80, and BCL2L11 were also expressed at higher levels in CD27
lo cells than in
CD27
hi or in undivided cells (n56 subjects, SAM analysis q values in Supplementary Table 1). ({) at least one probe significantly different between CD27
lo
and CD27
hi at FDR50.03, SAM analysis, (*)CD27
lo/Undivided, at least one probe significant, FDR50.01, (**)CD27
lo/undivided at least one probe
significant at FDR50.008. (b) AICDA, IL2RA, and CCL22 mRNA levels were confirmed by qRT-PCR. CCL22 levels between CD27
hi and undivided cells
were not significantly different (n510 subjects, paired T-test p values in Supplementary Table 2). The point in each violinplot is the median value and the
brackets indicate the interquartile range. AID protein was expressed in higher levels in divisions 1 and 2, where CD27
lo cells predominate. Representative
data from 1 subject shown, n54 subjects in 2 separate experiments. (c) Gene array analysis showed that while AICDA, IL2RA, and EXO1 were more
abundant in CD27
lo cells, many other germinal center markers were at higher levels in undivided cells. Naı ¨ve cell markers CD5 and ABCB1 were not
expressed in amounts that would indicate naı ¨ve cell contamination. (d) Expression levels of 7 GC-associated genes were confirmed by qRT-PCR.
www.nature.com/scientificreports
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using an unpaired t-test.
We also examined variation in cell surface protein levels with cell
divisionbyflowcytometry.CD80proteinlevelswerehigherinearlier
cell divisions, which is consistent with higher numbers of CD27
lo Bc
in these divisions. In contrast, CD83 protein expression levels
dropped after division 2 (Fig. 2c), which correlated with higher
levels of CD27
hi cells in later generations. While these data do not
preclude antigen presentation/co-stimulation by CD27
lo cells, they
better support an alternative hypothesis that undivided Bc might
better serve this function.
We next examined cytokine transcript expression between the
three cell types (Fig. 2d). A number of murine models have demon-
stratedphenotypesofregulatoryBc(Breg),characterizedbypatterns
of cytokine secretion (reviewed in
3). Human and murine Breg pro-
duce several cytokines including: IFN-c, IL-4, IL-6, IL-10, LT-a,
TNF-a and IL12
3 as well as IL-1a, IL-1b, IL-8
14, and IL-7
21. After
CpGstimulation,wefoundveryfewcytokinetranscriptsproducedin
CD27
lo cells. IFNA1, IFNB1, IFNG, IL-1b, IL-4, IL-8, IL10, IL-12a
and IL13, were not differentially expressed. Transcripts for IL-6, IL-
7,andIL-24were differentially expressed intheundivided cells, with
minimal expression in CD27
hi and CD27
lo proliferating Bc subsets
(Fig.2d).RelativechangesinIL-6transcriptlevelswereconfirmedby
qRT-PCR (Fig. 2e). Also of interest, low but statistically significant
levels of IL-15 mRNA were produced by CD27
hi cells (Fig. 2d). This
finding is consistent with IL-15 production reported by others in
plasma cells
22. IL-15 expression suggests the possibility of paracrine
stimulation, with CD27
hi cells secreting IL-15 to support prolifera-
tion of CD27
lo cells.
Overall, it was the CpG-stimulated but undivided mBc, not the
CD27
lo cells, that produced higher transcript levels for proteins with
key roles in antigen presentation, co-stimulation and cytokine pro-
duction.
AID is upregulated in CD27
lo populations. As the non-antibody
secreting CD27
lo cells resulting from CpG stimulation of IgG class
switched mBc did not express antigen presenting or cytokine
transcripts, we looked for other transcriptome patterns differentially
expressed in CD27
lo cells to identify other potential functional roles for
these cells.
Figure 4 | B cell development molecules are expressed at intermediate levels by CD27
lo cells. (a) Intermediate levels of many B cell development
molecules in CD27
lo cells suggest a transient phenotype consistent with developing pre-plasmablasts engaged in receptor editing before differentiation
(n56 subjects, SAM analysis q values in Supplementary Table 1). ({) at least one probe significantly different between CD27
lo and CD27
hi at FDR50.03,
SAM analysis, (*)CD27
lo/Undivided, at least one probe significant, FDR50.01, (**)CD27
lo/undivided at least one probe significant at FDR50.008. (b)
QuantitativeRT-PCRconfirmedrelativeRNAlevelsofBACH2,CD27,PRDM1(BLIMP-1),XBP-1,IgL,andHSPA5(BiP)(n510subjects,pairedT-test
p values in Supplementary Table 2). The point in each violinplot is the median value and the brackets indicate the interquartile range.
Figure 5 | The Fate of CD27
lo cells. We sorted normal human mBc at
60 hrs of stimulation with CpG1C Ka n dp l a c e di s o l a t e dC D 2 7
hi,
CD27
lo, and undivided cells back into culture with fresh
CpG1cytokines. Flow cytometric analysis 48 hrs later showed that
CD27
hi cells remained CD27
hi, while CD27
lo cells became CD27
hi.T h i s
supports the hypothesis that CD27
lo cells are a transient population
which differentiate into CD27
hi cells. N54s u b j e c t si n3s e p a r a t e
www.nature.com/scientificreports
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lo cells expressed significantly higher levels of activation-
induced cytidine deaminase (gene symbol AICDA, protein abbre-
viated AID) mRNA than CD27
hi or undivided CpG stimulated
mBc (Fig. 3a). This was also confirmed by quantitative RT-PCR
(Fig. 3b). Flow cytometric data showed increased intracellular AID
protein after divisions 1 and 2, where CD27
lo cells predominate,
and a reduced amount beyond division 3 (Fig. 3c). Upregulation of
AICDA, a regulator of Ig gene rearrangements
23, suggested an
alternative hypothesis that these CpG stimulated, IgG1 mBc were
capable of receptor editing before committing to a plasma cell
phenotype. AID activity can be induced by TLR activation and
can also be an indicator of receptor editing which typically occurs
in the germinal center
24,25. The CD27
lo subpopulation also had
higher levels of EXO1, a double-stranded DNA exonuclease
required for somatic hypermutation
23 (Fig. 3a), as well as the IL-
2 receptor alpha (IL-2Ra/CD25), a marker of Bc activation in the
germinal center
26.H o w e v e r ,C D 2 7
lo Bc did not differentially
express other genes found in germinal center Bc such as BCL6,
CD19, CD40, CD44, LTA, CD20, PAX5, SPIB, STAT6, TNF,
LRMP, TCL1A, PTPRC (CD45), WEE1, and BCL3 (Fig. 3d).
Quantitative rt- PCR confirmed expression levels of BCL6,
CD19, CD40, PAX5, PTPRC, STAT6, and TCL1A (Fig. 3e).
Although one possible interpretation of increased AICDA in
CD27lo cells is contamination by naı ¨ve Bc, we did not see differ-
ential expression of CD5 or ABCB1 by CD27
lo cells (Fig. 3d).
OthertranscriptomeelementssignificantlyupregulatedinCD27
lo
B cells. Genes of interest found to be significantly upregulated in
CD27
lo cells in comparison with CD27
hi cells included not only
AICDA and CD80 (Fig. 3a), but also chemokine ligand 22
(CCL22), BCL2L11 (Bim) a regulator of apoptosis in Bc, and
suppressor of cytokines 2 (SOCS2), a cytokine-induced modulator
of Jak/Stat pathways that down-regulates cytokine signaling
27, IL-5-
induced CISH
28, and HRAS, which had been shown to mediate ERK
activation in response to B cell receptor activation
29. This suggested a
mechanism for cross-talk between BCR ligation and cytokine
receptor signaling of the adaptive immune response, and the
antigen independent activation of the TLR9 triggered Bc response.
As shown in Figure 2b, qRT-PCR for relative RNA levels of CD80
showed statistically significant differences between each subset.
While the differences in CCL22 expression between CD27
hi and
CD27
lo as assessed by qRT-PCR were significant, the differences
between CD27
hi and undivided cells were not (Fig. 3b). Also, the
IL2Ra gene was differentially expressed between CD27
hi and CD27
lo
cells by qRT-PCR but not between CD27
lo and undivided cells.
Several other genes were identified by SAM analysis as signifi-
cantly higher in expression in CD27
lo cells, although at low overall
expression levels (Fig. 3a). These included ITGAL (CD11a), which
along with ITGB2 (CD18) can form LFA-1, a germinal center adhe-
sion complex, but corresponding expression levels of ITGB2 were
not seen. Interestingly, RCAN1, which inhibits calcineurin, a signal
transduction modulator between TLR, cytokines, and NF-kB
30, was
also differentially expressed in CD27
lo cells. Like SOCS2, this could
provide feedback inhibition of cytokine-induced signaling in acti-
vated Bc after CpG stimulation.
CD27
lo cells express intermediate levels of B cell differentiation
transcripts. If CpG-stimulated CD27
lo cells were a transient
population, undergoing receptor editing before further diffe-
rentiation, we hypothesized that they should have levels of Bc
differentiation markers that are higher than undivided cells and
lower than CD27
hi cells. Indeed, we found differential expression of
many proteins associated with Bc and plasma cell differentiation
(Fig. 4a). These included CD27 and CD38, markers associated with
antibody secreting plasmablasts in vivo and in vitro
17, and
immunoglobulin genes. Similarly, expression of HSPA5 (BiP)
mRNA, a protein involved in the secretion of immunoglobulin and
other proteins
31 was also higher in CD27
hi cells. Decreases in
expression levels between CD27
lo and CD27
hi cells were seen for
CD19, a pan-B cell marker which markedly down-regulated in
plasma cell differentiation, and CD20 (MS4A1; reviewed in
11).
Consistent with previous observations
9, large increases in the
mature plasma cell marker syndecan-1 (SDC1 or CD138)
transcripts were not seen in this pre-plasmablast population.
Overall, the data suggested a progression of transcription patterns
towards plasma cell differentiation starting with undivided cells,
progressing through CD27
lo and then CD27
hi cells with the most
pronounced plasma cell transcriptome pattern. CD27
hi cells exhib-
ited a transcription pattern associated with plasma cell differenti-
ation. This included increased PRDM1 (Blimp), a transcription
factor that drives plasma cells differentiation and represses the
mature Bc program; and the transcription factor XBP1 which is
induced by Blimp and is associated with antibody secretion
32.
Consistent with this pattern, expression of BACH2, atranscriptional
repressor of PRDM1
33 was decreased. IRF4, an inhibitor of Blimp
andarepressor of BCL6
34increased in expression levelin the CD27
hi
population as compared with CD27
lo. PAX5, which induces
BACH2
11 was differentially expressed in undivided cells, as were
BCL6 and IRF8, which is consistent with a mBc phenotype and
repression of the plasma cell phenotype
11. RUNX2, was produced
at higher levels in CD27
hi cells than in undivided cells, while the
inverse was true of RUNX3, a mBc transcript. For all these tran-
scripts, intermediate levels were expressed inCD27
lo cells,consistent
withCD27
locellshavingatransientphenotypebetweenthatofundi-
vided cells and CD27
hi cells. Quantitative RT-PCR confirmed differ-
entialexpressionofCD27,Igl,HSPA5,BACH2,XBP1,andPRDM1
genes (Fig. 4b).
To further explore the outcome of CD27
lo cell division we sorted
cells at 60hrs of CpG1CK stimulation (Fig. 5) and placed them back
into culture for 48 hrs. As expected, CD27
hi cells remained CD27
hi
and continued to proliferate, consistent with a pre-plasmablast or
plasmablast phenotype. CD27
lo cells did not remain CD27
lo, but
increased in CD27 expression as they proliferated. This is consistent
withacellpopulation that hadcompleted transitionto aplasmablast
phenotypeandsupportstheconclusionthattheCD27
lopopulationis
transient.
Network Analysis. We next performed transcriptome network
analysis through the use of Ingenuity Pathways Analysis, looking
for possible connecting pathways between the input stimuli of our
in vitro stimulation protocol (IL-2, IL-10, IL-15, BAFF, and CpG)
and the observed phenotypes of CD27
lo and CD27
hi cells (Fig. 6).
There are at least two pathways active in Bc not involving the Bc
receptor that can result in the CD27
lo phenotype. First, TLR9 can
activate NF-kB
35, which has been shown to be a marker of receptor
editing in Bc
36. Gene targets of NF-kB that we found to be
upregulated in CD27
lo cells include IL2RA, BCL2L11, CD80, and
AICDA. This cluster of upregulated NF-kB targets suggests that
NF-kB may be active in the CD27
lo subpopulation. In a second
activation pathway, IL-2 and IL-15 through action of the common
IL-2receptorc-chain,canactivatevariousJak/STATproteins
37,38.IL-
10 can also activate STAT3
39which can increase production of IRF4,
a key regulator of Bc differentiation.
GradedproductionofIRF4cantriggerdifferentBcellresponses
34.
Induced at low levels, of IRF4 can trigger production of AICDA,
whichwefoundupregulatedinCD27
locells.Inducedathigherlevels,
IRF4 induces production of PRDM-1, a key plasmablast develop-
ment gene, which was upregulated in CD27
hi cells. This provides a
means by which the same stimulation conditions can result in either
cell phenotype and a mechanism with which CD27
lo cells might
progress to a CD27
hi phenotype as IRF4 levels increase over time.
IRF4 also increases the activation of XBP1, a critical regulator of
immunoglobulin production upregulated in CD27
hi cells. HSPA5
www.nature.com/scientificreports
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of XBP1 and was found to be upregulated in CD27
hi cells.
NF-kB can also activate transcription of SPIB, which may also
provide another point of interaction of the CD27
lo network with
PRDM1 (BLIMP1), a key regulator of plasmablast (CD27
hi) differ-
entiation
11. PRDM1 expression, in turn, represses BCL6
34,40 and
AICDA
34. So while there are separate pathways to the two pheno-
types, these pathways appear to have points of reciprocal regulation.
Extensive differences in transcriptome profiles between CpG-
stimulated memory B cell subsets. Supplementary Table S1 lists
2,747 probes with statistically significant differences between
CD27
lo and CD27
hi cell subpopulations (SAM analysis, FDR50.03).
In addition to the gene sets examined for our hypotheses, other genes
of interest were differentially expressed between the cell subsets.
These are clustered here into gene sets that are relatively
upregulated or downregulated as cells transit from undivided to
CD27
lo to CD27
hi phenotypes.
Figure7Ashowsaheatmapofselectedgenes.Increasedinexpress-
ion with cell division were messages including: SLAMF7, a CD2
family member that induces Bc proliferation
41; TNFRSF17 (BCMA
or CD269) a receptor for the plasma cell survival factor BAFF; IL6
receptor and IL6 signal transducer (IL6ST), which together transmit
IL-6 signals to stimulate Bc division; low-density-lipoprotein recep-
tor (LDLR) which can be a marker of Bc activation; and IFN-a
receptor 2 (IFNAR2); as well as CD59, a potent complement inhib-
itor and possible signaling molecule
42. Relative RNA levels of CD59,
IL6R, and TNFRSF17 (BCMA) were confirmed by qRT-PCR
(Fig. 7b).
A number of genes of interest were downregulated with cell divi-
sion (Fig. 7a) including FCRL family members FCRLA, FCRL1,
FCRL3, and FCRL4. While CD27
lo cells showed intermediate
expression of FCRL4, they didnot co-express other molecules assoc-
iated with FCRL4
1 cells including RANKL (TNFSF11), CCNB2
(Fig. 7a), or RUNX2 (Fig. 4a), so this is a unique population. Also
downregulated was FAM129C, a Bc specific transcript, chemokine
receptors CCR6, CCR7 and CXCR5; FOXP1, an essential early Bc
transcriptional regulator
43; IL-4 receptor and SLAMF6, a member of
the CD2 family expressed on resting Bc
44. Relative levels of FCRL3,
FAM129C, CCR6, CCR7, IL4R, and CXCR5 were confirmed by
qRT-PCR (Fig. 7b). These changes are consistent with resting Bc
differentiating into plasmablasts and point to new molecules that
could be explored as markers of antibody production.
NovelmarkersofBcsubsetsthatsecreteantibodyareofinterestin
thatisolationofIg-secretingcellsbasedonsurfaceexpressionofIgor
otherknowncellsurfacemarkersisdifficult.EvenCD27
hicellsubsets
generally have only 50% of cells producing antibody
18. Given the
increase in CD59 transcripts in the CD27
hi subset gene array, we
confirmed expression with qRT-PCR (Fig. 7c) and examined the
utility of CD59 as a marker for IgG-producing cells. We stimulated
normal human mBc for 96 hrs with CpG and cytokines and found
that at the protein level, CD27
hi cells were CD59
hi (Fig. 7d). Also,
CD59 protein expression increased with cell division, but no more
than 50% of CD59
hi cells in any generation stained for intracellular
IgG(Fig.7e).CD59appearedsimilarto,butnotbetterthan,CD27as
a marker for discriminating these populations.
Discussion
An increasingly sophisticated understanding of the human CD271
classswitchedBcrecallresponseisemergingfromstudiesidentifying
subpopulationsofactivatedhumanmBc.Theseresponsesareknown
tobeheterogeneous
4,11,withantibodysecretingcells,cytokinesecret-
ing cells
45, antigen presenting and co-stimulatory
20 cells, and a mBc
Figure 6 | Model of possible network connecting stimulation conditions and induced proteins based on available findings. The same stimulation
conditionscanresultineitherCD27
loorCD27
hiphenotypesandprogressionfromonetotheother.CpG,throughTLR9,canactivateNW2kB,amarker
of receptor editing in Bc. Gene targets of NF-kB include several genes shown to be upregulated in CD27
lo cells (in gold), including AICDA. BAFF
(TNFSF13)alsohasbeenshowntoincreaseAICDAproduction.Inaseparatepathway,Jakproteins,includingJak3canbeactivatedthroughactionofthe
common gamma chain cytokines, IL2 or IL-15, resulting in the phosphorylation of STAT proteins such as STAT3, STAT5, and STAT6. IL-10 can also
activateSTAT3.STAT3,byitselforwithSTAT6canincreaseproductionofIRF4,akeyregulator ofBcdifferentiation.InductionofIRF4atlowlevelscan
stimulatetheproductionofAICDA,aproductofNF-kBandathigherlevels,IRF-4inducesproductionofPRDM-1,akeyplasmablastregulator.Thus,as
IRF-4 levels increase cells may progress from CD27
lo phenotype to a CD27
hi phenotype. NF-kB can also activate transcription of SPIB which negatively
regulates PRDM1 (BLIMP1). PRDM1 then represses BCL6 and AICDA. PRDM1, STAT6, and IRF4 can also enhance production of XBP1 which is
necessary for immunoglobulin production. HSPA5 (BiP), a mediator of immunoglobulin folding is also a target of XBP1 and is upregulated in CD27
hi
cells.
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46 all emerging within the same memory recall response.
Understanding the division of labor between the various activated
mBc subsets, particularly when altered by adjuvant during vaccina-
tion,mayallowustobiastheresponsetofavoronesetoffunctions.It
is for this reason that we focused on TLR-9 activated CD27
1 mBc, as
CpG ODN adjuvants are being actively developed to augment vac-
cine responses
47,48.
Previous transcriptome analyses of Bc subsets have examined dif-
ferential gene expression in mouse naı ¨ve and memory subsets from
spleen,orhumanBcfromtonsil
49,50,identifyingdifferentnumbersof
genesorprobes(50-450humangenes,,3,000murinegenes,,5,500
murine probes) differentially expressed between Bc subsets. Our
results demonstrated ,2,000 differentially expressed genes between
the pairs of the activated memory Bc subsets at a FDR50.03. There
areseveralkeydifferencesinstudymethodologythataccountforthis
difference with the human studies. First, a number of these papers
used a mathematical pattern recognition method which did not spe-
cifyafalsediscoveryorlevelofstatisticalsignificance,sothequantity
of differentially expressed genes are not directly comparable. Also,
these studies did not examine the differences between dividing,
Figure 7 | Other genes of interest differentially expressed between the cell subsets. (a) Heatmap of selected genes of interest. Genes that increase in
expression with cell division include: SLAMF7, TNFRSF17 (BCMA) IL6 receptor and IL6 signal transducer (IL6ST), low-density-lipoprotein receptor
(LDLR)amarkerofBcactivation;andIFN-areceptor2(IFNAR2);aswellasCD59,aninhibitorofcomplementandpossiblesignalingmolecule.Genesof
interest downregulated with cell division include FCRL family members, FAM129C, CCR6, CCR7 and CXCR5; FOXP1, IL-4 receptor and SLAMF6.
CD27
lo cells showed intermediate expression of FCRL4, and did not co-express other molecules associated with FCRL41 cells including RANKL
(TNFSF11), and CCNB2. (b) Relative expression levels of select genes were confirmed by qRT-PCR. The point in each violin plot is the median value
and the brackets indicate the interquartile range. (n510 subjects, paired T-test p values in Supplementary Table 2). We explored the utility of CD59 as a
surrogate marker of IgG expression. (c) Relative gene expression levels of CD59 were confirmed by quantitative RT-PCR. (d) CD59 and CD27 are both
expressed at higher levels in the same population of cells as assessed by flow cytometric analysis. (e) CD59 expression increased with cell division, but no
morethan50%ofCD59
hicellsinanysinglegenerationstainedforintracellularIgG.Representativedatafrom1subjectshown,n54subjectsin2separate
experiments.
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contrast, we report transcriptome analysis on subpopulations of sti-
mulated mBc based on generation and the expression of CD27. In
addition, many of these reports used an older gene array with 12,000
probe sets, compared to our use of second generation gene arrays
with ,54,000 probe sets. Indeed, many B cell and cell division spe-
cific genes lacked corresponding probes in the older arrays. Finally,
our results suggest a novel functional division between the prolif-
erating and undivided populations of CpG activated, class switched
mBc, as well as several potential feedback mechanisms that may
regulate the partitioning of CpG activated, class switched mBc
into antibody secreting, receptor editing, and antigen-presenting
phenotypes.
Several groups have described patterns of cytokine secretion by
activated murine and human Bc in vivo and in vitro
3,51. Stimulation
by synthetic CpG-B class ODN, such as the CpG2006 used in our
experiments,hasbeenreportedtoinduceup-regulationofactivation
markers, IL-12, and IL-6 by Bc in bulk culture
52. We found CpG-
induced IL-6, IL-7, IL-15, and IL-24 transcripts at the highest levels
intheactivatedbutundividedBcpopulation.IL-24belongstotheIL-
10 family of cytokines, and has been reported to inhibit plasma cell
differentiation of human germinal center Bc
53. It is notable that IL-6
and IL-7 were the other predominant cytokine genes highly
expressed in the undivided sub-population. IL-7 expression and sig-
naling is associated with recombination activating genes in germinal
center Bc
54, and IL-6 acts as an autocrine growth and differentiation
factor. However, in our experimental system, CpG-stimulation of
class-switched mBc does not appear to induce strong, polarizing
cytokine secretion associated with classical Breg functions of Th1
versus Th2 immune response deviation
3.
Although derived from an in vitro system, our finding of contem-
poraneous transcription of IL-6, IL-7, and IL-24 genes do suggest a
possible mechanism for activated but undivided mBc to regulate
CD27
losub-populationswithinagerminalcenterorTcellindepend-
ent lymphoid follicle. Active gene expression and secretion of these
cytokines by undivided Bc could regulate Bc subsets expressing high
levels of the IL-6R, IL-7R, and IL20/22R complexes, leading to sup-
pression of plasma celldifferentiation while supporting proliferation
and receptor editing in a subset of the CpG activated Bc. Consistent
withthishypothesisisourfindingthatCD27
locellsareaproliferating
but non-antibody secreting population, with a gene expression pat-
tern suggesting receptor editing and affinity maturation potential.
The availability of such adaptive mechanisms after antigen-inde-
pendent Bc activation also suggests a linkage between innate and
adaptiveBcresponses,suggestingfurthermechanismsfortheactions
of vaccine adjuvants, and targets for future in vivo studies.
Of note, we also found that the undivided cells were not inactive,
but appear to have an antigen presentation/co-stimulation pheno-
type, as suggested by high transcript levels of class II HLA antigens
and CD83. We show that these transcripts were generally downre-
gulated by CpG1CK, with intermediate levels in the proliferating
CD27
lopopulation. The exceptions are CD80 and CD86 whose tran-
scripts are increased in CD27
lo cells. In addition to their role in Tcell
co-stimulation, these proteins are upregulated on CpG-activated
mBc and, when engaged can increase the antibody production
55.
This suggests that CD80 and CD86 may play a role in activating
antibody production within the CD27
lopopulation. This might pro-
videapathwayforCD4potentiationofantibodysecretionduringthe
transition from T cell-independent CpG activation to a more T cell-
dependent adaptive immune response.
Also of interest, we found that the CD27
lo Bc subpopulation
expresses AICDA and precedes CD27
hi cells in Bc development.
Transcriptome profiling by others found AICDA expression in bulk
cultures of stimulated mBc
56. Our study points to the CD27
lo sub-
population as being the primary producers of AICDA in such sys-
tems. CpG is known to stimulate proliferation in CD27
- mBc
population found in healthy human subjects and enriched in SLE
patients
57. This Bc population was also reported to be FCRL4
-, while
the proliferating CD27
lo population that we describe here had a
higher FCRL4 expression compared to expanding CD27
hi cells.
Like FCRL4
1 Bc identified in other studies
2, the CD27
lo cells also
expressed higher amounts of AICDA, SOX5, and ITGAX, than
CD27
hi cells, while other markers of FCRL4
1 cells (RUNX2,
CCNB2, and TNFSF11) were not co-expressed. Thus, while there
are similarities between the CD27
lo subpopulation in CpG1CK-
stimulated mBc and the populations described by others, the
CD27
lo transitional phenotype described here is unique.
Finally, our work suggests another potential point of interaction
between co-cultured CpG-stimulated mBc subsets that could stimu-
late further studies. IL-6 receptors and IL6ST were upregulated in
CD27
hi subpopulation, indicating a mechanism through which the
activatedbutundividedBcsubpopulation,whichproducesIL-6tran-
scripts, might support plasmablast development. Others have pro-
posed a Bc IL-6 signaling autocrine loop
58, although it is beyond the
scope of this study to confirm it in this system.
The gene regulatory network model generated from our data
implies a dependency of CD27
lo subpopulation development and
AICDA expression upon NF-kB activation. Although receptor edit-
ing in early Bc has been associated with NF-kB activation
36,i ti s
difficult to assess alterations of NF-kB signaling in mBc, as early
Bc development can be severely compromised by NF-kB disrup-
tion
59. There is a recent case report of reduced NF-kB signaling in
EBV-transformed Bc from two patients with mBc deficiencies
60.
While our analyses suggest that NF-kB may play a role in develop-
ment of the CD27
lo subpopulation, due to the redundancy of cellular
signaling, other pathways may yet be found that provide that role as
well.
Methods
Human Subjects Protection.This study was approved by the Research Subjects
Review Board at the University of Rochester Medical Center. Informed consent was
obtained fromall participants. Research data werecoded such that subjectscould not
be identified, directly or through linked identifiers, in compliance with the
DepartmentofHealth andHuman ServicesRegulationsforthe ProtectionofHuman
Subjects (45 CFR 46.101(b)(4)).
Myeloma Cell Culture. Myeloma cell lines were maintained in log-phase growth as
previously described
61 and used for controls in flow cytometry: MPR-1130
(established in our laboratory), MC/CAR and Ramos cell lines (ATCC, Manassas,
VA).
B Cell Isolation and CpG activation. Human peripheral blood mononuclear cells
were isolated by Ficoll gradient centrifugation as previously described
9. Negative
magneticimmunoaffinitybeadseparation(MiltenyiBiotec,Auburn,CA)wasusedto
isolate total Bc. Anti-IgM-PE antibody (BD Biosciences, San Diego, CA) and anti-PE
beads (Miltenyi Biotec, Auburn, CA) were used to deplete IgM expressing naı ¨ve and
mBc. Pacific Blue Succinimidyl Ester (PBSE) (Carlsbad, CA, USA). Flow cytometric
analysis was performed on all isolates, showing .90% purity of the isolates.
FreshlyisolatedCD271IgGenrichedhumanperipheralbloodBcwereculturedin
thepresenceofCpG2006(10 ng/ml,Oligos,etc.,Wilsonville,OR),plusrecombinant
human cytokines IL-2 (20 IU/ml), IL-10 (50 ng/ml), IL-15 (10 ng/ml) (all from BD
Biosciences, San Diego, CA), and recombinant human BAFF (75 ng/ml, Chemicon,
Temecula, CA) PC-L medium (IMDM medium, lacromin (50mg/ml, Seracare,
Milford, MA), insulin (5mg/ml, Sigma-Aldrich, St. Louis, MO), penicillin/strep-
tomycin (1x, Invitrogen, Carlsbad, CA), gentamicin (15mg/ml, Invitrogen), heat-
inactivated fetal bovine serum (10% v/v, Invitrogen), normocin (0.1% v/v, Invivogen,
San Diego, CA) in round-bottomed 96-well plates (BD Biosciences, San Diego, CA).
All cells were cultured at 37uC, 5% CO2.
Flow Cytometric Analysis. Data on Bc surface and intracellular markers and CFSE
labeling was collected as previously described
9 on an LSR II cytometer with FACS
Diva data acquisition software. Antibodies used for cytometry included anti-CD27-
APC-H7,anti-IgG-PE-CY5, CD83-PECy7(BDBioscience, San Diego,CA)anti-AID
(Cell Signalling), antiCD59-APC (abCAM), anti-CD80-Alexa 647 (Serotec), anti-
CD19-PE-Cy7, anti-murine IgG-Alexa A680 (Invitrogen), Data was gated, analyzed
and displayed using Flowjo software (Treestar, Ashland, OR).
Fluorescence-Activated Cell Sorting. CFSE-stained cells were harvested, washed,
and counted. The cells were stained with Live/Dead Violet (Invitrogen, Carlsbad,
CA), washed and stained with anti-CD27-APC-H7 antibody (BD Bioscience, San
www.nature.com/scientificreports
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performed at the University of Rochester Medical Center Flow Cytometry Core
Facility.
Transcriptional Analysis. Human CD271 IgG enriched mBc labeled with
PBSE (Invitrogen) and stimulated with the CpG1CK or CD40L1IL-4 for 80 hours
round-bottomed 96-well plates. The cells were harvested, washed, counted, stained
withanti-CD27-APC-H7(BD biosciences), and Live/DeadGreen (LifeTechnologies,
Carlsbad,CA).Thecellsfromeachdonorweresortedintothreesamples–Undivided,
DividingCD27low,andDividingCD27high.ThecellsweresuspendedinRLTbuffer
(RNeasy Kit for RNA Isolation, Qiagen, Hilden, Germany), homogenized with a
QIAshredder column, and snap frozen in liquid nitrogen. A core facility, the
Functional Genomics Center at the University of Rochester, carried out sample
carried out cDNA generation using the WR-Ovation Pico System (NuGEN
Technologies, San Carlos, CA). Data from the hybridized Affymetrix U133 Plus 2.0
chipswasnormalizedusingtheGCRMAmethod.Theopen-sourcestatisticalpackage
R-Bioconductor, Excel (Microsoft, Redmond,WA), Partek Genomic Suite (St. Louis,
MO) and Ingenuity Pathways Analysis (Ingenuity, Redwood City, CA) software
programs were used for analysis and comparisons. Custom software developed in
Mathematica (Wolfram, Champaign, IL) was used to generate heatmaps. A copy of
the software is available for download at https://cbim.urmc.rochester.edu/software.
Quantitative RT-PCR. Quantitative RT-PCR was performed by the Functional
Genomics Center at the University of Rochester, a core facility. Ten sample sets were
analyzed by qRT-PCR, the same 6 sets of RNA analyzed by gene array, and an
additional 4 set of cells from different subjects, stimulated and sorted with the same
conditions. Immediately after collection, sorted cells were lysed in RLT buffer and
passed through a Qiashredder column (both from Qiagen, Germantown, MD)
and snap frozen in liquid nitrogen. Samples were stored at 270uC until RNA
extraction. RNA was extracted using the RNeasy Micro Kit with on-column DNAse
as recommended by the manufacturer (Qiagen). Quantitative RT-PCR was
performed on three experimental replicates per sample in TaqManH Array Fast
Plates with TaqManH Universal PCR Master Mix, No AmpEraseH UNG on the
StepOnePlus
TMReal-TimePCRSystem(LifeTechnologies,Carlsbad,CA)with10 ng
cDNA into each 10 ul reaction. RNA quality was confirmed by the presence of intact
rRNA with an Agilent 2100 Bioanalyzer (Santa Clara, CA).
For analysis, relative quantity (RQ) values for each gene were calculated using
DDCT (Cq) method
62. Cq values for each gene were normalized to total RNA content
using 18S RNA, normalized to each other using the first sample in the submitted
batch,anUndividedsampleandthenre-normalizedtothemeanoffourcontrolgenes
chosen from the gene array data, B2M, TERF21P, USP11, and RPL8.
Statistical Analysis. For gene array significance estimates, we applied a modified t-
statistic (paired version) by Significance Analysis of Micorarrays (SAM) method
63
using the Bioconductor package in R (www.bioconductor.org). A paired t-test was
used to compare qRT-PCR datasets. For the genes that contained negative (zero)
values, significance was confirmed using an independent t-test. Violin plots for each
gene, showing mean and standard deviation of normalized RQ values for each cell
population were constructed using the Using R package in R.
Antibody Coated Paramagnetic Bead Preparation. Antibody coated paramagnetic
beads were prepared by a modification of our previously published protocol
18.
Paramagnetic microspheres 8 mm (Bangs Lab, Fishers, IN) 10, 12, 16 or 30 mmi n
diameter (Micromod DE, Germany) were coated with streptavidin (Sigma-Aldrich,
St. Louis, MO) using a commercial kit (PolyLink Coupling Kit, Bangs Lab, Fishers,
IN). Additional SA was attached to 10 or 16 micron beads using an 8-branch PEG
polymer with amino linker groups (NOF America, White Plains, NY). Streptavidin-
coated beads were incubated in photocleavable-biotin-IgG solution (PC-IgG)
(Human IgG from Sigma, PC-biotinylation kit (Ambergen, Watertown, MA). All
beads werewashed overnight in phosphate-buffered saline (PBS) plus 2% w/v bovine
serum albumin at room temp with slow mixing on a rotator. Bead concentration was
determined by manual count using a hemocytometer (VWR, Westchester, PA).
PairedELISA-ELISPOTassays. ForbothqELISPOTandELISAassays,captureAb-
coated, control wells of 96 well assay plates were seeded with IgG bearing beads, each
bead type in triplicate wells. The ELISPOT plates were placed on large rare-earth
magnets to settle the magnetic beads rapidly to the well membrane for antibody
release. The IgG was released from the beads with a 35 min 365 nm UV exposure
from a Black-Ray UV lamp (UVP, Upland, CA), with a 10 min incubation in place
before washing.
MatchingELISPOTandELISAplateswereplatedwith9replicatewellsofbeadsfor
standard curve generation to relate total IgG released with spot density. Plates for
cellular ELISPOT assay were pre-spotted with triplicate wells of each bead standard.
Bc were collected, washed, counted with trypan blue for viability to calculate live cell
numbers for plating. At each time point, ELISPOT plates were developed as prev-
iously published
18.
ELISA plates were processed by incubation for 1 hour at 37uC with horseradish
peroxidase-conjugated goat-anti-human IgG in PBS with 2% BSA, washed, and then
incubated with bovine-anti-goat IgG-HRP in PBS 1 2% BSA for 1 at room tem-
perature. Color was developed using ABTS One Component Microwell Substrate
(Southern Biotech, Birmingham, AL) and read at 450 nm on a Benchmark Plus
microplate spectrophotometer (Bio-Rad, Hercules, CA).
ELISPOT and ELISA Reagents. Capture Ab, for ELISPOT and ELISA assays
consisted of Mouse anti-Human IgG (H1L) (Jackson, West Grove, PA). For
ELISPOT detection, we employed phosphatase-conjugated Goat anti-Human IgG
(Jackson, West Grove, PA), for ELISA detection, peroxidase-conjugated Goat anti-
Human IgG and peroxidase-conjugated bovine anti-goat IgG, standard curves made
with human IgG F(ab)2 fragment (Jackson, West Grove, PA).
Network Analysis. A data set containing genes of interest and corresponding
expression values was uploaded into Ingenuity Pathways Analysis (http://
ingenuity.com/). Each identifier was mapped to its corresponding object in
Ingenuity’s Knowledge Base. Network Eligible molecules, were overlaid onto a global
molecular network developed from information contained in Ingenuity’s Knowledge
Base. Networks of Network Eligible Molecules were then algorithmically generated
based on their connectivity.
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